Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amarnath Challapalli

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|February 10, 2016
New radiotracers in gynecological cancer: beyond ¹⁸F-FDGAmarnath Challapalli
Frontiers in Oncology|March 15, 2016
Positron Emission Tomography Imaging of Tumor Cell Metabolism and Application to Therapy Response MonitoringAmarnath Challapalli, Eric O Aboagye
Expert Review of Pharmacoeconomics & Outcomes Research|October 30, 2015
Health-related quality of life in men with metastatic castration-resistant prostate cancerAbigail Gee, Amarnath Challapalli, Amit Bahl
Clinical and Translational Imaging|June 10, 2017
Molecular mechanisms of hypoxia in cancerAmarnath Challapalli, Laurence Carroll, Eric O Aboagye
International Journal of Clinical Practice|May 9, 2021
Rectal spacers in patients with prostate cancer undergoing radiotherapy: A survey of UK uro-oncologistsAmit Bahl, Amarnath Challapalli, Suneil Jain, et al.
Acta Clinica Croatica|March 20, 2023
ROLE OF ANDROGEN RECEPTOR-TARGETED AGENTS IN LOCALIZED PROSTATE CANCERJure Murgić, Ana Fröbe, Amarnath Challapalli, et al.
Clinical Nuclear Medicine|July 17, 2013
Thyroid lymphoma incidentally detected by 18F-fluorocholine (FCH) PET/CTAmy Eccles, Amarnath Challapalli, Sameer Khan, et al.
Clinical and Translational Radiation Oncology|June 22, 2018
Evaluating the prevalence and predictive factors of vasomotor and psychological symptoms in prostate cancer patients receiving hormonal therapy: Results from a single institution experienceAmarnath Challapalli, Steve M Edwards, Paul Abel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 20, 2026
Long-term outcomes from a multicentre study of HDR monotherapy with a single fraction of 19 Gy for localized prostate cancerWiwatchai Sittiwong, Anna Lydon, James Wylie, et al.
Pediatric Blood & Cancer|June 13, 2006
Cervical paraganglioma--a case report and review of all cases reported to the Manchester Children's Tumour Registry 1954-2004Amarnath Challapalli, Lisa Howell, Martin Farrier, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|February 10, 2016
New radiotracers in gynecological cancer: beyond ¹⁸F-FDGAmarnath Challapalli
Frontiers in Oncology|March 15, 2016
Positron Emission Tomography Imaging of Tumor Cell Metabolism and Application to Therapy Response MonitoringAmarnath Challapalli, Eric O Aboagye
Expert Review of Pharmacoeconomics & Outcomes Research|October 30, 2015
Health-related quality of life in men with metastatic castration-resistant prostate cancerAbigail Gee, Amarnath Challapalli, Amit Bahl
Clinical and Translational Imaging|June 10, 2017
Molecular mechanisms of hypoxia in cancerAmarnath Challapalli, Laurence Carroll, Eric O Aboagye
International Journal of Clinical Practice|May 9, 2021
Rectal spacers in patients with prostate cancer undergoing radiotherapy: A survey of UK uro-oncologistsAmit Bahl, Amarnath Challapalli, Suneil Jain, et al.
Acta Clinica Croatica|March 20, 2023
ROLE OF ANDROGEN RECEPTOR-TARGETED AGENTS IN LOCALIZED PROSTATE CANCERJure Murgić, Ana Fröbe, Amarnath Challapalli, et al.
Clinical Nuclear Medicine|July 17, 2013
Thyroid lymphoma incidentally detected by 18F-fluorocholine (FCH) PET/CTAmy Eccles, Amarnath Challapalli, Sameer Khan, et al.
Clinical and Translational Radiation Oncology|June 22, 2018
Evaluating the prevalence and predictive factors of vasomotor and psychological symptoms in prostate cancer patients receiving hormonal therapy: Results from a single institution experienceAmarnath Challapalli, Steve M Edwards, Paul Abel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 20, 2026
Long-term outcomes from a multicentre study of HDR monotherapy with a single fraction of 19 Gy for localized prostate cancerWiwatchai Sittiwong, Anna Lydon, James Wylie, et al.
Pediatric Blood & Cancer|June 13, 2006
Cervical paraganglioma--a case report and review of all cases reported to the Manchester Children's Tumour Registry 1954-2004Amarnath Challapalli, Lisa Howell, Martin Farrier, et al.
Pageof 4